Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VARIVAX (2007 Process) and M-M-R II in Healthy Children
NCT00822237Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jan 2009
- Primary completion
- Oct 2009
- Modality
- Prophylactic Vaccines, DNA Vaccines, Live Biotherapeutic Products
01
Overview
A Phase 3 trial of varicella virus vaccine live in varicella (VZV), sponsored by Merck & Co.. Started Jan 2009; status: completed.
02
Drugs
varicella virus vaccine live
03
Conditions
varicella (VZV)
Beyond the preview
Go deeper on NCT00822237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00822237.